{"name":"Jing Zhou","slug":"jing-zhou","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2024-10-31","type":"pipeline","source":"South China Morning Post","summary":"AstraZeneca’s China president under ‘ongoing investigation’: company - South China Morning Post","headline":"AstraZeneca’s China president under ‘ongoing investigation’: company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBqeTYzNnBlYW9sSTlESHAya2JtbFZWb2FaQzRfX1UybDdwTS10YVpPdGpySDV2UWxWd1pCdG1tQVg3eVRNNmI5LWh0OWk0U1g3NS1NNTFuQWZva1YzQnNv?oc=5","date":"2024-02-04","type":"pipeline","source":"nature.com","summary":"DNA barcoding of Notopterygii Rhizoma et Radix (Qiang-huo) and identification of adulteration in its medicinal services - nature.com","headline":"DNA barcoding of Notopterygii Rhizoma et Radix (Qiang-huo) and identification of adulteration in its medicinal services","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9mbHNmS0hTaVFOQXlxcHFGVERva0dCYUJkQVZZUklDelJTRVhmWUZQYjUxRFdZcmU2MkFCTGJSX0xPSkZNRjB5Sm5UR3g0U2xSYzdiNlI5amhpMDF3WWE4RVg2WHNOR05FYmdEMnBB?oc=5","date":"2023-08-22","type":"pipeline","source":"ahajournals.org","summary":"Brain α2δ-1–Bound NMDA Receptors Drive Calcineurin Inhibitor–Induced Hypertension | Circulation Research - ahajournals.org","headline":"Brain α2δ-1–Bound NMDA Receptors Drive Calcineurin Inhibitor–Induced Hypertension | Circulation Research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE1BbTBVRmZpZmd0dHpwZGxfaVNCMzc0N3V4MUl3MUYxSDh4QWtybHRtNTJTR0kwOEh6YVA1VThFOC1TOExCWElSU3dqWlVtR29BUFRpTFE0cm51YTZ1bVpLYk95OFhCYkNX?oc=5","date":"2023-04-22","type":"trial","source":"Wiley Online Library","summary":"A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia - Wiley Online Library","headline":"A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE4tRWlxeGVGTG5ueWhzQmk2Ukg3Z0wxQmFaemx3NjdXZXRyc1BFQllKN2gycHBQM2RpZDdLbk5DS3FTdmhrXzhqek9XbGJCVlVWNVA2X0FEdFZzRU9uR2c?oc=5","date":"2018-07-06","type":"pipeline","source":"nature.com","summary":"Lactate potentiates angiogenesis and neurogenesis in experimental intracerebral hemorrhage - nature.com","headline":"Lactate potentiates angiogenesis and neurogenesis in experimental intracerebral hemorrhage","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTFB0R3BYTlp1cjFncnNFSWxyaU8wZU1sQjA1OGxKbVFhN1dZVVhUTGxpdDMzdUlROE9rNkV1cTZubTdKaVhYWmpwdXBaaFdpSVFsUFJoanFOZk1GcDFZWjJFelFSNFRwX2M?oc=5","date":"2017-09-11","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"CAR-T in the Courts - Genetic Engineering and Biotechnology News","headline":"CAR-T in the Courts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE40OUgwR0tfZjNlN3BOZFZsOFRkSW9MeUx4YjEtc3VHZDRHWnYzUmU1NElCQjhvUmFocEdUOThTc1M3UklYdjNXb1VRZWVkNlF2UGJHT1k0eXRSU2F1WHRNbE45VUZRb0NnNnVCcEstdjdoVzhQWWNiTnVB?oc=5","date":"2017-09-04","type":"pipeline","source":"Dignity Memorial","summary":"Min Zhou Obituary - Raleigh, NC - Dignity Memorial","headline":"Min Zhou Obituary - Raleigh, NC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTFAwVWxLNzM3alk3cG9WZFFLcVk5UkRrM0dVYUtQWEFOaWh6aFJleWIybW9aek80TUQ5RUNrZjFjblVpQ3g1blZYcWhKbFdNSTBRUTFfdkNfVFR2UkhhaURxTFVJaGNLbWQwaFBra1RmYi00S1R6Vm90Tw?oc=5","date":"2017-08-11","type":"pipeline","source":"China Daily","summary":"Journalists search for Three Kingdoms culture in Jingzhou[1] - China Daily","headline":"Journalists search for Three Kingdoms culture in Jingzhou[1]","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPd2hnOTJ4R0tFWHN0enpPaVlwUFhrb3U5OGhKUW04MHpFbTk0VklGRXBUMk1CU0ZLcnJnTGlvdkxpd3Z3UkN0dGpjNzY5U29lNjNjRVBMemZzTFpZaWE5QzlnTW0xSTR2aWVGbnZ4OEpUT09uOWFrbHNpeC1ZeC1qSzR3YUtkV1kwSEVmRmI3OUJfOXFOcnJPaFJkUkNCZm81cEFoWFg3QjlxY25iM2Z4eDdzWEx6aWlTYVE?oc=5","date":"2017-02-28","type":"pipeline","source":"Caixin Global","summary":"Pharmaceutical Giants Find Elixir in Updated China Drug Catalog - Caixin Global","headline":"Pharmaceutical Giants Find Elixir in Updated China Drug Catalog","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE11TUxLdDNMX2V0dmliQTQtdk90V1RnMXFCcU5MNmdLMW9fUzBOUkZWZURlY3A1R2JrcnN0TVNjZW5kN0hoMjlyTmRWd015YjhwVG9z?oc=5","date":"2016-05-16","type":"pipeline","source":"nature.com","summary":"Preclinical PK/PD model for combined administration of erlotinib and sunitinib in the treatment of A549 human NSCLC xenograft mice - nature.com","headline":"Preclinical PK/PD model for combined administration of erlotinib and sunitinib in the treatment of A549 human NSCLC xeno","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}